The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression

Autor: Sanith Cheriyamundath, Nancy Gavert, Avri Ben-Ze'ev, Anmol Kumar, Thomas Brabletz
Rok vydání: 2021
Předmět:
0301 basic medicine
Male
Smad2 Protein
medicine.disease_cause
Metastasis
lcsh:Chemistry
Small hairpin RNA
Transactivation
0302 clinical medicine
Ezrin
Cell Movement
Intestinal Mucosa
lcsh:QH301-705.5
Spectroscopy
Cell adhesion molecule
Chemistry
Procollagen-Lysine
2-Oxoglutarate 5-Dioxygenase

Liver Neoplasms
Wnt signaling pathway
General Medicine
Transfection
L1
Computer Science Applications
Gene Expression Regulation
Neoplastic

030220 oncology & carcinogenesis
Colonic Neoplasms
colonic crypts
Collagen
lysyl hydroxylase 2
Mice
Nude

Neural Cell Adhesion Molecule L1
colorectal cancer
Catalysis
Article
Inorganic Chemistry
03 medical and health sciences
Cell Line
Tumor

medicine
Animals
ddc:610
Smad3 Protein
Physical and Theoretical Chemistry
Molecular Biology
PLOD2
Organic Chemistry
medicine.disease
Xenograft Model Antitumor Assays
invasion and metastasis
ezrin
Cytoskeletal Proteins
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
Cancer research
Carcinogenesis
Zdroj: International Journal of Molecular Sciences
Volume 22
Issue 7
International Journal of Molecular Sciences, Vol 22, Iss 3552, p 3552 (2021)
ISSN: 1422-0067
Popis: The overactivation of Wnt/β-catenin signaling is a hallmark of colorectal cancer (CRC) development. We identified the cell adhesion molecule L1CAM (L1) as a target of β-catenin-TCF transactivation in CRC cells. The overexpression of L1 in CRC cells confers enhanced proliferation, motility, tumorigenesis and liver metastasis, and L1 is exclusively localized in the invasive areas of human CRC tissue. A number of genes are induced after L1 transfection into CRC cells by a mechanism involving the cytoskeletal protein ezrin and the NF-κB pathway. When studying the changes in gene expression in CRC cells overexpressing L1 in which ezrin levels were suppressed by shRNA to ezrin, we discovered the collagen-modifying enzyme lysyl hydroxylase 2 (PLOD2) among these genes. We found that increased PLOD2 expression was required for the cellular processes conferred by L1, including enhanced proliferation, motility, tumorigenesis and liver metastasis, since the suppression of endogenous PLOD2 expression, or its enzymatic activity, blocked the enhanced tumorigenic properties conferred by L1. The mechanism involved in increased PLOD2 expression by L1 involves ezrin signaling and PLOD2 that affect the SMAD2/3 pathway. We found that PLOD2 is localized in the colonic crypts in the stem cell compartment of the normal mucosa and is found at increased levels in invasive areas of the tumor and, in some cases, throughout the tumor tissue. The therapeutic strategies to target PLOD2 expression might provide a useful approach for CRC treatment.
Databáze: OpenAIRE